These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6896784)

  • 21. Advances in chemotherapy for large cell lymphoma.
    Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.
    Rossini F; Terruzzi E; Perego D; Miccolis I; Rivolta F; Manca E; Pogliani EM
    Cancer; 2004 Jan; 100(2):350-5. PubMed ID: 14716771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hodgkin's lymphoma--the great teacher.
    Connors JM
    N Engl J Med; 2011 Jul; 365(3):264-5. PubMed ID: 21774715
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hodgkin's disease of primary pericardial origin].
    Bosa Ojeda F; de Armas Trujillo D; Marrero Rodríguez F; Laynez Cerdeña I; Domínguez Pastor C; Martín Herrera A; Hernández Nieto L
    Med Clin (Barc); 1984 Jan; 82(2):74-6. PubMed ID: 6546775
    [No Abstract]   [Full Text] [Related]  

  • 25. More is not necessarily better when treating Hodgkin's lymphoma.
    Connors JM
    J Clin Oncol; 2011 Nov; 29(32):4215-6. PubMed ID: 21990411
    [No Abstract]   [Full Text] [Related]  

  • 26. [A three-year experience with use of mabthera (rituximab) in treatment of indolent non-Hodgkin's disease refractory to standard chemotherapy].
    Korolenko VO; Gershanovich ML; Tikhonova VV
    Vopr Onkol; 2004; 50(4):421-5. PubMed ID: 15605764
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of acute leukemias].
    Gross R; Gerecke D
    Wien Klin Wochenschr; 1982 Nov; 94(21):591-6. PubMed ID: 6963072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [EBV-positive diffuse large B-cell lymphoma in young individual: report of a case].
    Li WS; Xie JL; Zhang M; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):128-9. PubMed ID: 23710923
    [No Abstract]   [Full Text] [Related]  

  • 29. Bleomycin, epidoxorubicin, cyclophosphamide, vincristine and prednisone (BACOP) in patients with follicular non-Hodgkin's lymphoma: results of a prospective, multicenter study of the Gruppo Italiano Per Lo Studio Dei Linfomi (GISL).
    Lombardo M; Morabito F; Merli F; Molica S; Cavanna L; Sacchi S; Broglia C; Angrilli F; Ilariucci F; Stelitano C; Luisi D; Bertè R; Luminari S; Federico M; Brugiatelli M;
    Leuk Lymphoma; 2002 Sep; 43(9):1795-801. PubMed ID: 12685834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Escalated BEACOPP in advanced Hodgkin's lymphoma.
    Casasnovas O; Coiffier B
    Lancet; 2012 May; 379(9828):1767-8. PubMed ID: 22480757
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
    Papa G; Mandelli F; Anselmo AP; De Luca AM; Maurizienrici R; Mauro F; Testi AM; Amadori S; Biagini C
    Eur J Cancer Clin Oncol; 1982 Sep; 18(9):803-6. PubMed ID: 6185342
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term results of patients with advanced diffuse, non-Hodgkin's lymphoma treated with cyclophosphamide, doxorubicin, vincristine, prednisone and bleomycin (CHOP-Bleo).
    Case DC
    Oncology; 1983; 40(3):186-91. PubMed ID: 6189041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-cell non-Hodgkin lymphoma presenting as an endobronchial polypoid mass.
    Kaira K; Ishizuka T; Tanaka H; Tanaka Y; Ishizuka T; Yanagitani N; Sunaga N; Hisada T; Mori M
    J Thorac Oncol; 2008 May; 3(5):530-1. PubMed ID: 18449008
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased levels of tumor necrosis factor-α involved in rituximab-related acute pulmonary fibrosis in diffuse large B-cell lymphoma.
    Zhang X; Guo X; Pan J
    Am J Clin Pathol; 2015 May; 143(5):725-7. PubMed ID: 25873507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of non-Hodgkin lymphomas].
    Izzi T; Porcellini A; Delfini C; Lucarelli G
    Minerva Med; 1982 Apr; 73(15):949-53. PubMed ID: 7078792
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
    Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
    J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination chemotherapy of malignant histiocytosis.
    Palazzo E; Bergerat JP; Vetter JM; Boilletot A; Lang JM; Oberling F
    Acta Haematol; 1979; 62(5-6):251-6. PubMed ID: 95146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined therapy of lymphogranulomatosis].
    Vorob'ev AI; Fokina NT; Brilliant MD; Fil'kova EM
    Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):3-7. PubMed ID: 6895412
    [No Abstract]   [Full Text] [Related]  

  • 39. Combination chemotherapy.
    Old LJ; Krakoff IH
    Clin Bull; 1975; 5(3):120-3. PubMed ID: 1227737
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of concomitant antiblastic chemotherapy and highly active antiretroviral therapy on human immunodeficiency virus (HIV) viremia and genotyping in HIV-infected patients with non-Hodgkin lymphoma.
    Simonelli C; Zanussi S; Cinelli R; Dal Maso L; Di Gennaro G; D'Andrea M; Nasti G; Spina M; Vaccher E; De Paoli P; Tirelli U
    Clin Infect Dis; 2003 Sep; 37(6):820-7. PubMed ID: 12955644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.